EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective
Abstract
Authors
JG Ariza Moreno K Arciniegas G Montoya J Castellano C Tamayo A Gonzalez